BLFS FY 2023 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

FY 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$76M-0.5% YoY

Gross Profit

$47M61.6% margin

Operating Income

-$23M-30.9% margin

Net Income

-$66M-87.6% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$19M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$413M

Total Liabilities

$75M

Stockholders' Equity

$338M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$76M	-0.5%
Gross Profit	$47M	$47M	-0.3%
Operating Income	-$23M	-$6M	-295.7%
Net Income	-$66M	-$140M	+52.5%